IQVIA
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · North Carolina, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
2400 Ellis Rd, Durham, North Carolina, 2...Phone Number
(919) 998-2000Website
www.iqvia.comRevenue
$16.6 BillionStock Symbol
IQVIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
4
3
3
2
1
1
About IQVIA
IQVIA is a global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find solutions for their patients. IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing the information that helps their customers drive human health outcomes forward. IQVIAs insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. IQVIA has dual headquarters in Danbury Connecticut and Durham, North Carolina.Explore more
IQVIA Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is IQVIA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if IQVIA had a recent Job posting/layoffs
IQVIA, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if IQVIA is spiking on competitors!
Check if IQVIA has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on IQVIA recently announced quarterly report
Funding: Get notified immidiatlly once IQVIA has new funding data
Product Launch: Get notified when IQVIA launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at IQVIA
Recommended Actions
Find VP level buyers at IQVIA
Find 2 more new buyers
Products Owned by IQVIA
IQVIA Nexxus Marketing
Explore company insights
Get a deeper look into IQVIA's structure, leadership, and market position:
Company Profile Activity
Activity Insights
IQVIA is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
IQVIA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about IQVIA.
IQVIA financials insights
Gather financial insights about IQVIA, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Debt
$1.3B
IQVIA Tech Stack
A closer look at the technologies used by IQVIA
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
IQVIA News & Media
IQVIA Holdings Stock Outlook: Is Wall Street Bullish or Bearish?
Despite already outperforming the broader market over the past year, IQVIA continues to enjoy strong backing from Wall Street, with analysts remaining highly optimistic about the stock’s future prospects.IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery
RESEARCH TRIANGLE PARK, N.C. and BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, and Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company pioneering next-generation therapeutics for cardiovascular disease, today announced a strategic collaboration to accelerate the development of cardiac gene therapies and human-based dAn IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know
This insider disposed of 16% of direct holdings at $245.21 per share, while maintaining nearly 3,000 shares valued at $740,000.An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know
Sherbet's disposition leaves him with 20,999 directly held shares valued at $5.2 million as IQVIA trades near $238.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IQVIA
Sign Up For FreeTo access detailed company insights
IQVIA is a global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find solutions for their patients. IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthca... Read More
